Abstract
Purpose
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with a dismal prognosis which is, among others, due to a lack of suitable biomarkers and therapeutic targets. Previously, basic gene expression analysis methods have been used for their identification, but recently new algorithms have been developed allowing more comprehensive data analyses. Among them, weighted gene co-expression network analysis (WGCNA) has already been applied to several cancer types with promising results.
Methods
We applied WGCNA to miRNA expression data from PDAC patients. Specifically, we processed microarray-based expression data of 2555 miRNAs in serum from 100 PDAC patients and 150 healthy subjects. We identified network modules of co-expressed miRNAs in the healthy subject dataset and verified their preservation in the PDAC dataset. In the non-preserved modules, we selected key miRNAs and carried out functional enrichment analyses of their experimentally known target genes. Finally, we tested their prognostic significance using overall survival analyses.
Results
Through WGCNA we identified several miRNAs that discriminate healthy subjects from PDAC patients and that, therefore, may play critical roles in PDAC development. At a functional level, we found that they regulate p53, FoxO and ErbB associated cellular signalling pathways, as well as cell cycle progression and various genes known to be involved in PDAC development. Some miRNAs were also found to serve as novel prognostic biomarkers, whereas others have previously already been proposed as such, thereby validating the WGCNA approach. In addition, we found that these novel data may explain at least some of our previous PDAC gene expression analysis results.
Conclusions
We identified several miRNAs critical for PDAC development using WGCNA. These miRNAs may serve as biomarkers for PDAC diagnosis/prognosis and patient stratification, and as putative novel therapeutic targets.
Similar content being viewed by others
References
R.L. Siegel, K.D. Miller, A. Jemal, Cancer statistics, 2016. CA Cancer J Clin 66, 7–30 (2016)
M. Hidalgo, S. Cascinu, J. Kleeff, R. Labianca, J.M. Lohr, J. Neoptolemos, F.X. Real, J.L. Van Laethem, V. Heinemann, Addressing the challenges of pancreatic cancer: future directions for improving outcomes. Pancreatology 15, 8–18 (2015)
S. Majumder, S.T. Chari, D.A. Ahlquist, Molecular detection of pancreatic neoplasia: current status and future promise. World J Gastroenterol 21, 11387–11395 (2015)
D.P. Ryan, T.S. Hong, N. Bardeesy, Pancreatic adenocarcinoma. N Engl J Med 371, 1039–1049 (2014)
K. Andrikou, M. Santoni, F. Piva, A. Bittoni, A. Lanese, C. Pellei, A. Conti, C. Loretelli, A. Mandolesi, M. Giulietti, M. Scarpelli, G. Principato, M. Falconi, S. Cascinu, Lgr5 expression, cancer stem cells and pancreatic cancer: results from biological and computational analyses. Future Oncol 11, 1037–1045 (2015)
T.R. Donahue, L.M. Tran, R. Hill, Y. Li, A. Kovochich, J.H. Calvopina, S.G. Patel, N. Wu, A. Hindoyan, J.J. Farrell, X. Li, D.W. Dawson, H. Wu, Integrative survival-based molecular profiling of human pancreatic cancer. Clin Cancer Res 18, 1352–1363 (2012)
G. Zhang, A. Schetter, P. He, N. Funamizu, J. Gaedcke, B.M. Ghadimi, T. Ried, R. Hassan, H.G. Yfantis, D.H. Lee, C. Lacy, A. Maitra, N. Hanna, H.R. Alexander, S.P. Hussain, DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma. PLoS One 7, e31507 (2012)
M.R. Carlson, B. Zhang, Z. Fang, P.S. Mischel, S. Horvath, S.F. Nelson, Gene connectivity, function, and sequence conservation: predictions from modular yeast co-expression networks. BMC Genomics 7, 40 (2006)
S.L. Carter, C.M. Brechbuhler, M. Griffin, A.T. Bond, Gene co-expression network topology provides a framework for molecular characterization of cellular state. Bioinformatics 20, 2242–2250 (2004)
J.M. Stuart, E. Segal, D. Koller, S.K. Kim, A gene-coexpression network for global discovery of conserved genetic modules. Science 302, 249–255 (2003)
J.A. Miller, S. Horvath, D.H. Geschwind, Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways. Proc Natl Acad Sci U S A 107, 12698–12703 (2010)
Y.X. Wang, H. Huang, Review on statistical methods for gene network reconstruction using expression data. J Theor Biol 362, 53–61 (2014)
C.F. Staehler, A. Keller, P. Leidinger, C. Backes, A. Chandran, J. Wischhusen, B. Meder, E. Meese, Whole miRNome-wide differential co-expression of microRNAs. Genomics Proteomics Bioinformatics 10, 285–294 (2012)
M. Bhattacharyya, S. Bandyopadhyay, Studying the differential co-expression of microRNAs reveals significant role of white matter in early Alzheimer's progression. Mol BioSyst 9, 457–466 (2013)
C.C. Lin, R. Mitra, F. Cheng, Z. Zhao, A cross-cancer differential co-expression network reveals microRNA-regulated oncogenic functional modules. Mol BioSyst 11, 3244–3252 (2015)
B. Zhang, S. Horvath, A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol 4, 17 (2005)
M.C. Oldham, G. Konopka, K. Iwamoto, P. Langfelder, T. Kato, S. Horvath, D.H. Geschwind, Functional organization of the transcriptome in human brain. Nat Neurosci 11, 1271–1282 (2008)
I. Voineagu, X. Wang, P. Johnston, J.K. Lowe, Y. Tian, S. Horvath, J. Mill, R.M. Cantor, B.J. Blencowe, D.H. Geschwind, Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474, 380–384 (2011)
P.S. Gargalovic, M. Imura, B. Zhang, N.M. Gharavi, M.J. Clark, J. Pagnon, W.P. Yang, A. He, A. Truong, S. Patel, S.F. Nelson, S. Horvath, J.A. Berliner, T.G. Kirchgessner, A.J. Lusis, Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proc Natl Acad Sci U S A 103, 12741–12746 (2006)
R. Liu, C.X. Guo, H.H. Zhou, Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifen. Cancer Biol Ther 16, 317–324 (2015)
C. Clarke, S.F. Madden, P. Doolan, S.T. Aherne, H. Joyce, L. O'Driscoll, W.M. Gallagher, B.T. Hennessy, M. Moriarty, J. Crown, S. Kennedy, M. Clynes, Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis. Carcinogenesis 34, 2300–2308 (2013)
Y.S. Lee, S.G. Hwang, J.K. Kim, T.H. Park, Y.R. Kim, H.S. Myeong, J.D. Choi, K. Kwon, C.S. Jang, Y.T. Ro, Y.H. Noh, S.Y. Kim, Identification of novel therapeutic target genes in acquired lapatinib-resistant breast cancer by integrative meta-analysis. Tumour Biol 37, 2285–2297 (2015)
Z. Mousavian, A. Nowzari-Dalini, R.W. Stam, Y. Rahmatallah, A. Masoudi-Nejad, Network-based expression analysis reveals key genes related to glucocorticoid resistance in infant acute lymphoblastic leukemia. Cell Oncol 40, 33–45 (2017)
M. Giulietti, G. Occhipinti, G. Principato, F. Piva, Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development. Cell Oncol 39, 379–388 (2016)
M. Diab, I. Muqbil, R.M. Mohammad, A.S. Azmi, P.A. Philip, The role of microRNAs in the diagnosis and treatment of pancreatic adenocarcinoma. J Clin Med 5, E59 (2016)
V. Taucher, H. Mangge, J. Haybaeck, Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application. Cell Oncol 39, 295–318 (2016)
C. Yu, M. Wang, Z. Li, J. Xiao, F. Peng, X. Guo, Y. Deng, J. Jiang, C. Sun, MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1. Cell Oncol 38, 173–181 (2015)
M.L. Abba, N. Patil, J.H. Leupold, H. Allgayer, MicroRNA regulation of epithelial to mesenchymal transition. J Clin Med 5, E8 (2016)
M. Beuran, I. Negoi, S. Paun, A.D. Ion, C. Bleotu, R.I. Negoi, S. Hostiuc, The epithelial to mesenchymal transition in pancreatic cancer: a systematic review. Pancreatology 15, 217–225 (2015)
F. Piva, M. Giulietti, M. Santoni, G. Occhipinti, M. Scarpelli, A. Lopez-Beltran, L. Cheng, G. Principato, R. Montironi, Epithelial to mesenchymal transition in renal cell carcinoma: implications for cancer therapy. Mol Diagn Ther 20, 111–117 (2016)
Y. Xue, A.N. Abou Tayoun, K.M. Abo, J.M. Pipas, S.R. Gordon, T.B. Gardner, R.J. Barth Jr., A.A. Suriawinata, G.J. Tsongalis, MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm. Cancer Gene Ther 206, 217–221 (2013)
N.A. Schultz, C. Dehlendorff, B.V. Jensen, J.K. Bjerregaard, K.R. Nielsen, S.E. Bojesen, D. Calatayud, S.E. Nielsen, M. Yilmaz, N.H. Hollander, K.K. Andersen, J.S. Johansen, MicroRNA biomarkers in whole blood for detection of pancreatic cancer. JAMA 311, 392–404 (2014)
J. Xu, Z. Cao, W. Liu, L. You, L. Zhou, C. Wang, W. Lou, B. Sun, Y. Miao, X. Liu, T. Zhang, Y. Zhao, Plasma miRNAs effectively distinguish patients with pancreatic cancer from controls: a multicenter study. Ann Surg 263, 1173–1179 (2016)
L. Moldovan, K.E. Batte, J. Trgovcich, J. Wisler, C.B. Marsh, M. Piper, Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med 18, 371–390 (2014)
M. Kojima, H. Sudo, J. Kawauchi, S. Takizawa, S. Kondou, H. Nobumasa, A. Ochiai, MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers. PLoS One 10, e0118220 (2015)
P. Langfelder, S. Horvath, WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008)
M.C. Oldham, P. Langfelder, S. Horvath, Network methods for describing sample relationships in genomic datasets: application to Huntington's disease. BMC Syst Biol 6, 63 (2012)
P. Langfelder, R. Luo, M.C. Oldham, S. Horvath, Is my network module preserved and reproducible? PLoS Comput Biol 7, e1001057 (2011)
E. Vauleon, A. Tony, A. Hamlat, A. Etcheverry, D.C. Chiforeanu, P. Menei, J. Mosser, V. Quillien, M. Aubry, Immune genes are associated with human glioblastoma pathology and patient survival. BMC Med Genet 5, 41 (2012)
Y. Fan, K. Siklenka, S.K. Arora, P. Ribeiro, S. Kimmins, J. Xia, miRNet - dissecting miRNA-target interactions and functional associations through network-based visual analysis. Nucleic Acids Res 44, W135-W141 (2016)
R. Aguirre-Gamboa, V. Trevino, SurvMicro: assessment of miRNA-based prognostic signatures for cancer clinical outcomes by multivariate survival analysis. Bioinformatics 30, 1630–1632 (2014)
P. Langfelder, S. Horvath, Eigengene networks for studying the relationships between co-expression modules. BMC Syst Biol 1, 54 (2007)
A.S. Bauer, A. Keller, E. Costello, W. Greenhalf, M. Bier, A. Borries, M. Beier, J. Neoptolemos, M. Buchler, J. Werner, N. Giese, J.D. Hoheisel, Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue. PLoS One 7, e34151 (2012)
S. Ali, K. Almhanna, W. Chen, P.A. Philip, F.H. Sarkar, Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer. Am J Transl Res 3, 28–47 (2010)
M. Miyamae, S. Komatsu, D. Ichikawa, T. Kawaguchi, S. Hirajima, W. Okajima, T. Ohashi, T. Imamura, H. Konishi, A. Shiozaki, R. Morimura, H. Ikoma, T. Ochiai, K. Okamoto, H. Taniguchi, E. Otsuji, Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer. Br J Cancer 113, 1467–1476 (2015)
M.S. Lin, W.C. Chen, J.X. Huang, H.J. Gao, H.H. Sheng, Aberrant expression of microRNAs in serum may identify individuals with pancreatic cancer. Int J Clin Exp Med 7, 5226–5234 (2014)
J. Liu, J. Gao, Y. Du, Z. Li, Y. Ren, J. Gu, X. Wang, Y. Gong, W. Wang, X. Kong, Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer 131, 683–691 (2012)
X. Kong, Y. Du, G. Wang, J. Gao, Y. Gong, L. Li, Z. Zhang, J. Zhu, Q. Jing, Y. Qin, Z. Li, Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. Dig Dis Sci 56, 602–609 (2011)
J. Wang, J. Chen, P. Chang, A. LeBlanc, D. Li, J.L. Abbruzzesse, M.L. Frazier, A.M. Killary, S. Sen, MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res 2, 807–813 (2009)
M. Bloomston, W.L. Frankel, F. Petrocca, S. Volinia, H. Alder, J.P. Hagan, C.G. Liu, D. Bhatt, C. Taccioli, C.M. Croce, MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297, 1901–1908 (2007)
M. Liu, Y. Du, J. Gao, J. Liu, X. Kong, Y. Gong, Z. Li, H. Wu, H. Chen, Aberrant expression miR-196a is associated with abnormal apoptosis, invasion, and proliferation of pancreatic cancer cells. Pancreas 42, 1169–1181 (2013)
F. Huang, J. Tang, X. Zhuang, Y. Zhuang, W. Cheng, W. Chen, H. Yao, S. Zhang, MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha. PLoS One 9, e87897 (2014)
R. Que, G. Ding, J. Chen, L. Cao, Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma. World J Surg Oncol 11, 219 (2013)
A.O. Batagov, V.A. Kuznetsov, I.V. Kurochkin, Identification of nucleotide patterns enriched in secreted RNAs as putative cis-acting elements targeting them to exosome nano-vesicles. BMC Genomics 12 Suppl 3, S18 (2011)
M. Giulietti, S.A. Milantoni, T. Armeni, G. Principato, F. Piva, ExportAid: database of RNA elements regulating nuclear RNA export in mammals. Bioinformatics 31, 246–251 (2015)
S. Volinia, G.A. Calin, C.G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, R.L. Prueitt, N. Yanaihara, G. Lanza, A. Scarpa, A. Vecchione, M. Negrini, C.C. Harris, C.M. Croce, A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103, 2257–2261 (2006)
B. Fu, M. Luo, S. Lakkur, R. Lucito, C.A. Iacobuzio-Donahue, Frequent genomic copy number gain and overexpression of GATA-6 in pancreatic carcinoma. Cancer Biol Ther 7, 1593–1601 (2008)
K.A. Kwei, M.D. Bashyam, J. Kao, R. Ratheesh, E.C. Reddy, Y.H. Kim, K. Montgomery, C.P. Giacomini, Y.L. Choi, S. Chatterjee, C.A. Karikari, K. Salari, P. Wang, T. Hernandez-Boussard, G. Swarnalata, M. van de Rijn, A. Maitra, J.R. Pollack, Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer. PLoS Genet 4, e1000081 (2008)
W.B. Chen, F.T. Huang, Y.Y. Zhuang, J. Tang, X.H. Zhuang, W.J. Cheng, Z.Q. Gu, S.N. Zhang, Silencing of GATA6 suppresses SW1990 pancreatic cancer cell growth in vitro and up-regulates reactive oxygen species. Dig Dis Sci 58, 2518–2527 (2013)
Y. Zhong, Z. Wang, B. Fu, F. Pan, S. Yachida, M. Dhara, E. Albesiano, L. Li, Y. Naito, F. Vilardell, C. Cummings, P. Martinelli, A. Li, R. Yonescu, Q. Ma, C.A. Griffin, F.X. Real, C.A. Iacobuzio-Donahue, GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1. PLoS One 6, e22129 (2011)
P. Martinelli, E. Carrillo-de Santa Pau, T. Cox, B. Sainz, Jr., N. Dusetti, W. Greenhalf, L. Rinaldi, E. Costello, P. Ghaneh, N. Malats, M. Buchler, M. Pajic, A.V. Biankin, J. Iovanna, J. Neoptolemos, F.X. Real, GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer. Gut. (2016). doi:10.1136/gutjnl-2015-311256
T. Nakamura, Y. Furukawa, H. Nakagawa, T. Tsunoda, H. Ohigashi, K. Murata, O. Ishikawa, K. Ohgaki, N. Kashimura, M. Miyamoto, S. Hirano, S. Kondo, H. Katoh, Y. Nakamura, T. Katagiri, Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 23, 2385–2400 (2004)
C.A. Iacobuzio-Donahue, A. Maitra, G.L. Shen-Ong, T. van Heek, R. Ashfaq, R. Meyer, K. Walter, K. Berg, M.A. Hollingsworth, J.L. Cameron, C.J. Yeo, S.E. Kern, M. Goggins, R.H. Hruban, Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol 160, 1239–1249 (2002)
S. Jones, X. Zhang, D.W. Parsons, J.C. Lin, R.J. Leary, P. Angenendt, P. Mankoo, H. Carter, H. Kamiyama, A. Jimeno, S.M. Hong, B. Fu, M.T. Lin, E.S. Calhoun, M. Kamiyama, K. Walter, T. Nikolskaya, Y. Nikolsky, J. Hartigan, D.R. Smith, M. Hidalgo, S.D. Leach, A.P. Klein, E.M. Jaffee, M. Goggins, A. Maitra, C. Iacobuzio-Donahue, J.R. Eshleman, S.E. Kern, R.H. Hruban, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V.E. Velculescu, K.W. Kinzler, Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801–1806 (2008)
A. Thakur, A. Bollig, J. Wu, D.J. Liao, Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice. Mol Cancer 7, 11 (2008)
S.J. Murphy, S.N. Hart, J.F. Lima, B.R. Kipp, M. Klebig, J.L. Winters, C. Szabo, L. Zhang, B.W. Eckloff, G.M. Petersen, S.E. Scherer, R.A. Gibbs, R.R. McWilliams, G. Vasmatzis, F.J. Couch, Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor. Gastroenterology 145, 1098–1109 e1091 (2013)
A.V. Biankin, N. Waddell, K.S. Kassahn, M.C. Gingras, L.B. Muthuswamy, A.L. Johns, D.K. Miller, P.J. Wilson, A.M. Patch, J. Wu, D.K. Chang, M.J. Cowley, B.B. Gardiner, S. Song, I. Harliwong, S. Idrisoglu, C. Nourse, E. Nourbakhsh, S. Manning, S. Wani, M. Gongora, M. Pajic, C.J. Scarlett, A.J. Gill, A.V. Pinho, I. Rooman, M. Anderson, O. Holmes, C. Leonard, D. Taylor, S. Wood, Q. Xu, K. Nones, J.L. Fink, A. Christ, T. Bruxner, N. Cloonan, G. Kolle, F. Newell, M. Pinese, R.S. Mead, J.L. Humphris, W. Kaplan, M.D. Jones, E.K. Colvin, A.M. Nagrial, E.S. Humphrey, A. Chou, V.T. Chin, L.A. Chantrill, A. Mawson, J.S. Samra, J.G. Kench, J.A. Lovell, R.J. Daly, N.D. Merrett, C. Toon, K. Epari, N.Q. Nguyen, A. Barbour, N. Zeps, N. Kakkar, F. Zhao, Y.Q. Wu, M. Wang, D.M. Muzny, W.E. Fisher, F.C. Brunicardi, S.E. Hodges, J.G. Reid, J. Drummond, K. Chang, Y. Han, L.R. Lewis, H. Dinh, C.J. Buhay, T. Beck, L. Timms, M. Sam, K. Begley, A. Brown, D. Pai, A. Panchal, N. Buchner, R. De Borja, R.E. Denroche, C.K. Yung, S. Serra, N. Onetto, D. Mukhopadhyay, M.S. Tsao, P.A. Shaw, G.M. Petersen, S. Gallinger, R.H. Hruban, A. Maitra, C.A. Iacobuzio-Donahue, R.D. Schulick, C.L. Wolfgang, R.A. Morgan, R.T. Lawlor, P. Capelli, V. Corbo, M. Scardoni, G. Tortora, M.A. Tempero, K.M. Mann, N.A. Jenkins, P.A. Perez-Mancera, D.J. Adams, D.A. Largaespada, L.F. Wessels, A.G. Rust, L.D. Stein, D.A. Tuveson, N.G. Copeland, E.A. Musgrove, A. Scarpa, J.R. Eshleman, T.J. Hudson, R.L. Sutherland, D.A. Wheeler, J.V. Pearson, J.D. McPherson, R.A. Gibbs, S.M. Grimmond, Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399–405 (2012)
F. Piva, M. Giulietti, G. Occhipinti, M. Santoni, F. Massari, V. Sotte, R. Iacovelli, L. Burattini, D. Santini, R. Montironi, S. Cascinu, G. Principato, Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in renal cell carcinoma. Oncotarget 6, 32161–32168 (2015)
F. Piva, M. Giulietti, L. Baldelli, B. Nardi, C. Bellantuono, T. Armeni, F. Saccucci, G. Principato, Bioinformatic analyses to select phenotype affecting polymorphisms in HTR2C gene. Humanist Psychol 26, 365–372 (2011)
F. Piva, M. Giulietti, B. Nardi, C. Bellantuono, G. Principato, An improved in silico selection of phenotype affecting polymorphisms in SLC6A4, HTR1A and HTR2A genes. Humanist Psychol 25, 153–161 (2010)
F. Bianchi, M. Raponi, F. Piva, A. Viel, I. Bearzi, E. Galizia, R. Bracci, L. Belvederesi, C. Loretelli, C. Brugiati, F. Corradini, D. Baralle, R. Cellerino, An intronic mutation in MLH1 associated with familial colon and breast cancer. Familial Cancer 10, 27–35 (2011)
B. Meder, C. Backes, J. Haas, P. Leidinger, C. Stahler, T. Grossmann, B. Vogel, K. Frese, E. Giannitsis, H.A. Katus, E. Meese, A. Keller, Influence of the confounding factors age and sex on microRNA profiles from peripheral blood. Clin Chem 60, 1200–1208 (2014)
H. Zhao, J. Shen, L. Medico, D. Wang, C.B. Ambrosone, S. Liu, A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 5, e13735 (2010)
R. Duttagupta, R. Jiang, J. Gollub, R.C. Getts, K.W. Jones, Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One 6, e20769 (2011)
J.N. Boeckel, C.E. Thome, D. Leistner, A.M. Zeiher, S. Fichtlscherer, S. Dimmeler, Heparin selectively affects the quantification of microRNAs in human blood samples. Clin Chem 59, 1125–1127 (2013)
S. Grasedieck, N. Scholer, M. Bommer, J.H. Niess, H. Tumani, A. Rouhi, J. Bloehdorn, P. Liebisch, D. Mertens, H. Dohner, C. Buske, C. Langer, F. Kuchenbauer, Impact of serum storage conditions on microRNA stability. Leukemia 26, 2414–2416 (2012)
G. Occhipinti, M. Giulietti, G. Principato, F. Piva, The choice of endogenous controls in exosomal microRNA assessments from biofluids. Tumour Biol 37, 11657–11665 (2016)
S.A. Melo, L.B. Luecke, C. Kahlert, A.F. Fernandez, S.T. Gammon, J. Kaye, V.S. LeBleu, E.A. Mittendorf, J. Weitz, N. Rahbari, C. Reissfelder, C. Pilarsky, M.F. Fraga, D. Piwnica-Worms, R. Kalluri, Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523, 177–182 (2015)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
ᅟ
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
Electronic supplementary material
ESM 1
(DOC 72 kb)
Rights and permissions
About this article
Cite this article
Giulietti, M., Occhipinti, G., Principato, G. et al. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis. Cell Oncol. 40, 181–192 (2017). https://doi.org/10.1007/s13402-017-0315-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13402-017-0315-y